Literature DB >> 21635935

MHC class II upregulation and colocalization with Fas in experimental models of immune-mediated bone marrow failure.

Andrew J Erie1, Leigh Samsel, Tomoiku Takaku, Marie J Desierto, Keyvan Keyvanfar, J Philip McCoy, Neal S Young, Jichun Chen.   

Abstract

OBJECTIVE: To test the hypothesis that γ-interferon (IFN-γ) promotes major histocompatibility complex (MHC) class II expression on bone marrow (BM) cell targets that facilitate T-cell-mediated BM destruction in immune-mediated BM failure.
MATERIALS AND METHODS: Allogeneic lymph node (LN) cells were infused into MHC- or minor histocompatibility antigen-mismatched hosts to induce BM failure. MHC class II and Fas expression and cell apoptosis were analyzed by flow cytometry. MHC class II-Fas colocalization was detected by ImageStream Imaging Flow Cytometry and other cell-to-cell associations were visualized by confocal microscopy. T-cell-mediated BM cell apoptosis and effects of IFN-γ on MHC class II-Fas colocalization on normal BM cells were studied using cell culture in vitro followed by conventional and imaging flow cytometry.
RESULTS: BM failure animals had significantly upregulated MHC class II expression on CD4(-)CD8(-)CD11b(-)CD45R(-) residual BM cells and significantly increased MHC class II-Fas colocalization on BM CD150(+) and CD34(+) hematopoietic cells. MHC class II(+)Fas(+) BM cells were closely associated with CD4(+) T cells in the BM of affected animals, and they were significantly more responsive to T-cell-mediated cell apoptosis relative to MHC class II(-)Fas(-) BM cells. Infusion of IFN-γ-deficient LN cells into minor histocompatibility antigen-mismatched recipients resulted in no MHC class II-Fas upregulation and no clinically overt BM failure. Treatment with recombinant IFN-γ significantly increased both MHC class II-Fas coexpression and colocalization on normal BM cells.
CONCLUSIONS: Elevation of the inflammatory cytokine IFN-γ-stimulated MHC class II expression and MHC class II-Fas colocalization, which may facilitate T-cell-mediated cell destruction. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21635935      PMCID: PMC3144292          DOI: 10.1016/j.exphem.2011.05.005

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  37 in total

1.  MHC class II structural requirements for the association with Igalpha/beta, and signaling of calcium mobilization and cell death.

Authors:  Lei Jin; John C Stolpa; Ryan M Young; Aimee E Pugh-Bernard; Yosef Refaeli; John C Cambier
Journal:  Immunol Lett       Date:  2007-12-26       Impact factor: 3.685

2.  MPYS, a novel membrane tetraspanner, is associated with major histocompatibility complex class II and mediates transduction of apoptotic signals.

Authors:  Lei Jin; Paul M Waterman; Karen R Jonscher; Cindy M Short; Nichole A Reisdorph; John C Cambier
Journal:  Mol Cell Biol       Date:  2008-06-16       Impact factor: 4.272

3.  Quantitative analysis of protein co-localization on B cells opsonized with rituximab and complement using the ImageStream multispectral imaging flow cytometer.

Authors:  Paul V Beum; Margaret A Lindorfer; Brian E Hall; Thaddeus C George; Keith Frost; Philip J Morrissey; Ronald P Taylor
Journal:  J Immunol Methods       Date:  2006-10-10       Impact factor: 2.303

4.  Minor antigen h60-mediated aplastic anemia is ameliorated by immunosuppression and the infusion of regulatory T cells.

Authors:  Jichun Chen; Felicia M Ellison; Michael A Eckhaus; Aleah L Smith; Keyvan Keyvanfar; Rodrigo T Calado; Neal S Young
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

5.  Aberrant MHC class II expression in mouse joints leads to arthritis with extraarticular manifestations similar to rheumatoid arthritis.

Authors:  Satoshi Kanazawa; Shusuke Ota; Chiyoko Sekine; Toyohiro Tada; Takanobu Otsuka; Takashi Okamoto; Grete Sønderstrup; B Matija Peterlin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-15       Impact factor: 11.205

6.  Proliferation and apoptosis of bone marrow CD4(+) T cells in patients with aplastic anemia and impacts of the secreted cytokines on hematopoietic stem cells from umbilical cord blood.

Authors:  Miao Zheng; Hanying Sun; Jianfeng Zhou; Huizhen Xu; Lifang Huang; Wenli Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-02-14

7.  The role of the Th1 transcription factor T-bet in a mouse model of immune-mediated bone-marrow failure.

Authors:  Yong Tang; Marie J Desierto; Jichun Chen; Neal S Young
Journal:  Blood       Date:  2009-11-10       Impact factor: 22.113

8.  Lymphocytes with aberrant expression of Fas or Fas ligand attenuate immune bone marrow failure in a mouse model.

Authors:  Stephanie O Omokaro; Marie J Desierto; Michael A Eckhaus; Felicia M Ellison; Jichun Chen; Neal S Young
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

Review 9.  Aplastic anemia.

Authors:  Neal S Young; Phillip Scheinberg; Rodrigo T Calado
Journal:  Curr Opin Hematol       Date:  2008-05       Impact factor: 3.284

10.  Generation of PLZF+ CD4+ T cells via MHC class II-dependent thymocyte-thymocyte interaction is a physiological process in humans.

Authors:  You Jeong Lee; Yoon Kyung Jeon; Byung Hyun Kang; Doo Hyun Chung; Chung-Gyu Park; Hee Young Shin; Kyeong Cheon Jung; Seong Hoe Park
Journal:  J Exp Med       Date:  2009-12-28       Impact factor: 14.307

View more
  4 in total

Review 1.  New therapeutic approaches for protecting hematopoietic stem cells in aplastic anemia.

Authors:  Wendy Weston; Vineet Gupta; Rebecca Adkins; Roland Jurecic
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

2.  LFA-1-targeting Leukotoxin (LtxA; Leukothera®) causes lymphoma tumor regression in a humanized mouse model and requires caspase-8 and Fas to kill malignant lymphocytes.

Authors:  Kristina M DiFranco; Nadine Johnson-Farley; Joseph R Bertino; David Elson; Brian A Vega; Benjamin A Belinka; Scott C Kachlany
Journal:  Leuk Res       Date:  2015-03-21       Impact factor: 3.156

Review 3.  Flow cytometry and solid organ transplantation: a perfect match.

Authors:  Orla Maguire; Joseph D Tario; Thomas C Shanahan; Paul K Wallace; Hans Minderman
Journal:  Immunol Invest       Date:  2014       Impact factor: 3.657

4.  [Tetramethylpyrazine promotes bone marrow repair in a C57 mouse model of X-rayinduced immune-mediated bone marrow failure].

Authors:  Xiaomin Zhang; Lei Gao; Xiao Hu; Shanshan Chen; Linghui Nie; Lingling Zhu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-08-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.